Date: 2015-11-29
Type of information: Collaboration agreement
Compound:
Company: Cell Therapy Catapult (UK) Kanagawa Prefecture (Japan)
Therapeutic area: Regenerative Medicine
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On November 27, 2015, the Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, announced the signing of a memorandum of understanding with the Kanagawa Prefecture of Japan. The agreement was signed between Kuroiwa Yuji, Governor of the Kanagawa Prefecture, and Keith Thompson, the CEO of the Cell Therapy Catapult. The agreement involves a commitment for cooperation in the promotion of the practical application and commercialisation of regenerative medicine and cell therapy in both Japan and the UK. The Cell Therapy Catapult, by co-operating with industry, academic institutions and the new Life Innovation Centre in Kanagawa Prefecture, is expected to provide partnerships that will enable both Japanese and British firms to internationalise the development of these advanced therapies. The Kanagawa Prefecture has the second largest population after Tokyo and contains considerable innovation in cell therapy and regenerative medicine. The Life Innovation Centre is strategically located next to Tokyo\'s Haneda International Airport providing for ease of logistics in shipping cell therapies between Tokyo, Japan and Cell Therapy Catapult facilities near Heathrow, London, UK.
Financial terms:
Latest news:
